570,556 snapshots · latest May 3, 2026
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
386,223 snapshots · latest Apr 14, 2026
243,880 snapshots · latest Apr 28, 2026
How to comply with procedures under Canada's Access to Medicines Regime Instructions for complying with the Requirements of Canada's Access to Medicines Regime specify how to notify the World Trade Organization or the Government of Canada, and how to request the addition of a…
Notification requirements for importing countries under Canada's Access to Medicines Regime Eligible countries are required to notify the World Trade Organization (WTO) or the Government of Canada of their plans to use Canada's Access to Medicines Regime . Each reporting…
Importing countries under Canada's Access to Medicines Regime An eligible country wanting to import a generic version of a patented drug or medical device under Canada's Access to Medicines Regime must meet the following requirements: Identify a drug or medical device that is on…
WTO-member countries and non-WTO member countries eligible to import under Canada's Access to Medicines Regime Patent Act WTO-Member Countries and Non-WTO Member Countries Eligible to Import Under the Regime An Act to amend the Patent Act and the Food and Drugs Act (Paragraph…
WTO-member countries eligible to import under Canada's Access to Medicines Regime Patent Act WTO-Member Countries Eligible to Import Under the Regime An Act to amend the Patent Act and the Food and Drugs Act (Paragraph 21.03(1)(c)) Albania Egypt Nicaragua Antigua and Barbuda El…
Least-developed countries eligible to import under Canada's Access to Medicines Regime Patent Act Least-Developed Countries Eligible to Import Under the Regime An Act to amend the Patent Act and the Food and Drugs Act (Paragraph 21.03(1)(b)) Afghanistan Gambia Rwanda Angola…
Countries eligible for Canada's Access to Medicines Regime The list of countries eligible to participate in Canada's Access to Medicines Regime includes countries that are members of the World Trade Organization (WTO). However, 23 member countries, including Canada, have…
Review process under Canada's Access to Medicines Regime Countries can be assured that products purchased under Canada's Access to Medicines Regime meet the same health and safety standards as products sold in Canada. Manufacturers are required to submit scientific evidence of a…
Capacity to manufacture under Canada's Access to Medicines Regime Canada's Access to Medicines Regime is designed to help least-developed and developing countries that have little or no manufacturing capacity in the pharmaceutical sector. To participate in the Regime, an eligible…
Features of Canada's Access to Medicines Regime The World Trade Organization (WTO) decision of August 2003 established the basic framework for a compulsory licence for export regime. Within that framework, each WTO member decides for itself how it will implement the decision…
Early release: coverage and features are still expanding.
